Using AI to help manage Myasthenia Gravis
Application of Artificial Intelligence to Construct Whole-person Precise Smart Medicine and Precise Health Care Program in Patients With Myasthenia Gravis
This study is testing a voice-based AI robot to see if it can help people with Myasthenia Gravis manage their health and get support more easily.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 10 (estimated) |
| Ages | 20 Years and up |
| Sex | All |
| Sponsor | National Taipei University of Nursing and Health Sciences Academic / other |
| Locations | 1 site (New Taipei City, Tamsui District) |
| Trial ID | NCT06879210 on ClinicalTrials.gov |
What this trial studies
This study proposes the development of an intelligent health robot that leverages artificial intelligence to assist patients with Myasthenia Gravis in managing their disease-related issues. By creating a voice-based AI program, the study aims to construct a dedicated platform that allows patients to access information and support remotely. This innovative approach seeks to enhance patient convenience and enable timely responses to health concerns.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 20 and above who have been diagnosed with Myasthenia Gravis and are able to use a smartphone.
Not a fit: Patients who are not diagnosed with Myasthenia Gravis or those who do not use smartphones may not benefit from this study.
Why it matters
Potential benefit: If successful, this could provide patients with Myasthenia Gravis a more accessible way to manage their condition and receive timely assistance.
How similar studies have performed: While the application of AI in healthcare is a growing field, this specific approach to assist Myasthenia Gravis patients is relatively novel and has not been extensively tested in similar studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients diagnosed with myasthenia gravis by a physician. 2. Age 20 years and above. 3. Able to use a smartphone. Exclusion Criteria: 1. Individuals not diagnosed with myasthenia gravis. 2. Individuals who do not use smartphones or tablets. 3. Individuals who withdraw from the group midway. 4. Individuals unwilling to participate in interviews.
Where this trial is running
New Taipei City, Tamsui District
- Yi Ting Yeh — New Taipei City, Tamsui District, Taiwan (Recruiting)
Study contacts
- Study coordinator: Yi Timg Yeh
- Email: reinating90@gmail.com
- Phone: +866-952-166-103
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.